Skip to main content
. Author manuscript; available in PMC: 2016 Mar 1.
Published in final edited form as: J Pediatr Gastroenterol Nutr. 2015 Mar;60(3):360–367. doi: 10.1097/MPG.0000000000000584

Table 3.

Lipid measures by resolution of NASH at 96 weeks

Resolution of NASH at 96 weeks
Mean(95% CI) Resolved
(N=52)
Not resolved
(N=69)
P* Adjusted
P
Non HDL-C(mg/dL)
  Baseline 137.3(127.4,147.2) 140.1(130.9,149.2) 0.69 0.71
  96 weeks 130.0(120.1,139.9) 141.2(131.7,150.7) 0.11 0.05
  Change from baseline −7.3(−14.9,0.2) 1.1(−5.7,7.9) 0.1 0.01

Triglycerides(mg/dL)
  Baseline 139.7(113.7, 165.7) 152.5(127.4, 177.5) 0.49 0.72
  96 weeks 161.4(132.3,190.6) 171.4(148.0,194.7) 0.59 0.3
  Change from baseline 21.7(−2.2,45.6) 18.9(−1.7,39.5) 0.86 0.28

HDL(mg/dL)
  Baseline 39.1(36.7,41.6) 36.5(34.3,38.7) 0.12 0.09
  96 weeks 36.4(34.5,38.4) 34.5(32.8,36.2) 0.14 0.07
  Change from baseline −2.7(−4.5,−0.8) −2.0(−3.6,−0.4) 0.56 0.42

LDL(mg/dL)
  Baseline 110.8(101.5,120.2) 109.0(102.5,115.4) 0.73 0.97
  96 weeks 99.8(90.6,109.1) 107.7(99.5,115.8) 0.21 0.16
  Change from baseline −11.2(−19.1,−3.3) −2.1(−7.6,3.4) 0.05 0.06

Total cholesterol(mg/dL)
  Baseline 176.4(166.0, 186.9) 176.6(166.8, 186.3) 0.99 0.96
  96 weeks 166.4(156.5, 176.3) 175.7(165.8, 185.6) 0.2 0.11
  Change from baseline −10.0(−18.0,−2.0) −0.9(−8.0,6.3) 0.09 0.02

Triglycerides/HDL
  Baseline 4.0(3.0,5.0) 4.4(3.7,5.1) 0.48 0.62
  96 weeks 4.8(3.8,5.9) 5.1(4.4,5.7) 0.69 0.31
  Change from baseline 0.9(0.2,1.5) 0.7(0.04,1.3) 0.72 0.35
*

P-values derived from univariable linear regression models.

Adjusted p-values derived from linear regression models and included treatment group, baseline BMI, ethnicity, and for change measures, the baseline value of the lipid measure